Denali Therapeutics Inc.

DNLI · XNAS

CIK 1714899fmd_1ECW73VNJTS0NDH1W979QZCZCBManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2016 to Sep 30, 2026, 40 periods